| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Feb 2026 | 5 Feb 2026 |
| Genesys International Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Approval of unaudited financial results (standalone & consolidated) for the quarter and nine months ended December 31 2025 In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations ), we wish to inform that the Board of Directors of the Company at its meeting held today i.e. on Thursday, February 12, 2026, inter alia, considered and approved the following: 1. Un-audited Financial Results (Standalone & Consolidated) for the third quarter and nine months ended December 31, 2025, along with Limited Review Report of Statutory Auditors. Copies of the following enclosed as Annexure-I: a. Un-audited Financial Results (Standalone & Consolidated) for the third quarter and nine months ended December 31, 2025. b. Limited Review Report of the Statutory Auditors on the aforesaid results . In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), we wish to inform that the Board of Directors of the Company at its meeting held today i.e. on Thursday, February 12, 2026, inter alia, considered and approved the following: 1. Un-audited Financial Results (Standalone & Consolidated) for the third quarter and nine months ended December 31, 2025, along with Limited Review Report of Statutory Auditors. Copies of following enclosed as Annexure-I: a. Un-audited Financial Results (Standalone & Consolidated) for the third quarter and nine months ended December 31, 2025. b. Limited Review Report of the Statutory Auditors on aforesaid results. (As Per BSE Announcement Dated on 12.02.2026) | ||
| Board Meeting | 13 Nov 2025 | 6 Nov 2025 |
| Genesys International Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve the un-audited financial results (standalone and consolidated) for the quarter and half year ended September 30 2025 Unaudited Financial Results (Standalone and Consolidated) for the second quarter and half year ended September 30, 2025 (As Per BSE Announcement Dated on: 13/11/2025) | ||
| Board Meeting | 13 Aug 2025 | 6 Aug 2025 |
| Genesys International Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve the un-audited financial results (standalone and consolidated) for the first quarter ended June 30 2025. Unaudited Financial Results (standalone and consolidated) for the first quarter ended June 30, 2025 along with Limited Review Report of statutory auditors (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 30 May 2025 | 27 May 2025 |
| Genesys International Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the audited financial results (standalone and consolidated) for the fourth quarter and financial year ended March 31 2025. In Compliance with Reg 30 and 33 of SEBI (LODR) Reg, 2015, the board of directors at its meeting held today approved the audited financial results (Standalone and Consolidated) for the quarter and year ended March 31, 2025 (As Per BSE Announcement Dated on: 30/05/2025) | ||
| Board Meeting | 14 May 2025 | 14 May 2025 |
| The QIP Committee at its meeting held today considered the opening of issue today i.e May 14, 2025, the preliminary placement document dated May 14, 2025, the relevant date for the purpose of the issue, the floor price in respect of the issue | ||
| Board Meeting | 20 Mar 2025 | 20 Mar 2025 |
| The Board of Directors of the Company in its meeting held today, March 20, 2025 inter alia approved the Unaudited Interim Condensed Consolidated Financial Statements for the nine months period ended December 31, 2024 along with the limited review report issued thereunder. This refers to our disclosure dated March 20, 2025 under Regulation 30 of SEBI (LODR) Regulations, 2015 filed with the exchange along with the Unaudited Interim Condensed Consolidated Financial Statements for the nine months period ended December 31, 2024. In this regard, please note that the Company inadvertently mentioned authorised capital as at December 31, 2024 as Rs. 2,550.00 lakh at note no. 7 of the Condensed Financial Statements instead of Rs. 2,725.00 lakh. (As Per BSE Announcement Dated on: 25/03/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
